1040 related articles for article (PubMed ID: 31847896)
1. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin.
Hai JJ; Wong YK; Wong CK; Un KC; Chan PH; Siu CW; Yiu KH; Lau CP; Tse HF
BMC Cardiovasc Disord; 2019 Jul; 19(1):168. PubMed ID: 31307391
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Wong YK; Chan YH; Hai JSH; Lau KK; Tse HF
Cardiovasc Diabetol; 2021 Apr; 20(1):88. PubMed ID: 33894788
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.
Yiu KH; Lau KK; Zhao CT; Chan YH; Chen Y; Zhen Z; Wong A; Lau CP; Tse HF
Cardiovasc Diabetol; 2014 Mar; 13():63. PubMed ID: 24661773
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
7. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
8. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
[TBL] [Abstract][Full Text] [Related]
9. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
[TBL] [Abstract][Full Text] [Related]
10. B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.
Jarolim P; Claggett BL; Conrad MJ; Carpenter MA; Ivanova A; Bostom AG; Kusek JW; Hunsicker LG; Jacques PF; Gravens-Mueller L; Finn P; Solomon SD; Weiner DE; Levey AS; Pfeffer MA
Transplantation; 2017 Jan; 101(1):182-190. PubMed ID: 26910333
[TBL] [Abstract][Full Text] [Related]
11. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia.
Puelacher C; Wagener M; Honegger U; Assadian M; Schaerli N; Mueller D; Strebel I; Twerenbold R; Boeddinghaus J; Nestelberger T; Wildi K; Sabti Z; Sazgary L; Badertscher P; du Fay de Lavallaz J; Marbot S; Kaiser C; Wild D; Zellweger MJ; Reichlin T; Mueller C
Clin Biochem; 2018 Feb; 52():33-40. PubMed ID: 29107010
[TBL] [Abstract][Full Text] [Related]
12. Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.
Wong YK; Cheung CYY; Tang CS; Au KW; Hai JSH; Lee CH; Lau KK; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2519-2527. PubMed ID: 30354221
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
[TBL] [Abstract][Full Text] [Related]
14. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
[TBL] [Abstract][Full Text] [Related]
16. Incremental value of B-type natriuretic peptide for detection and risk reclassification of obstructive coronary artery disease on computed tomography angiography.
Kawabe M; Sato A; Hoshi T; Endo M; Yoshida I; Aonuma K
J Cardiol; 2017 Apr; 69(4):671-677. PubMed ID: 27443597
[TBL] [Abstract][Full Text] [Related]
17. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Biochemical Markers on Major Adverse Cardiovascular Events and Contralateral Carotid Artery Stenosis Progression Following Carotid Interventions.
Stone PA; Thompson SN; Khan M; Northfield E; Schillinger R; Skaff P
Ann Vasc Surg; 2017 Jan; 38():144-150. PubMed ID: 27546852
[TBL] [Abstract][Full Text] [Related]
19. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
[TBL] [Abstract][Full Text] [Related]
20. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
